Image 1
Atazanavir Sulfate Capsule
Product Images NDC 0093-5528
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atazanavir Sulfate (NDC 0093-5528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a chart showing Atazanavir Plasma Concentration in ng/mL for two different doses of medication (ATV 400 mg and ATV/RTV 300/100 mg). The chart also includes the median wild-type EC50 value in ng/mL.*
Image 3
This is a description of a medication containing atazanavir sulfate. The medication comes in a capsule form that contains 150mg of atazanavir, and the suggested dosage can be found in the package insert. The medication should be stored in a tightly sealed container and out of the reach of children. It was manufactured in Croatia by Pliva Hrvatska and is distributed by Teva Pharmaceuticals USA. The text also contains some unclear characters that are not English.*
Image 4
This is a medication for Atazanavir Sulfate capsules, which comes with a warning alert. The pharmacist is instructed not to cover the ALERT box with pharmacy labels. The medication should be dispensed along with the attached patient information leaflet. The usual dosage is mentioned on the package insert, and the medication should be kept in a tight, light-resistant container, out of the reach of children. It is manufactured in Croatia for Teva Pharmaceuticals USA, Inc. No further information is available due to the presence of non-English characters in the text.*
Image 5
This is a medication information leaflet for Atazanavir Sulfate Capsules. The pharmacist is instructed not to cover the ALERT box with the pharmacy label. The patient is advised to find out about medicines that should not be taken with this medication. The usual dosage is available on the package insert. The medication should be stored at 20° to 25°C and kept out of the reach of children. The medication is manufactured in Croatia by Pliva Hrvatska d.0.0, and is manufactured for Teva Pharmaceuticals USA, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
